Outcomes of uveitic cataract and uveitic glaucoma surgery
Outcomes of uveitic cataract and uveitic glaucoma surgery
批准号:
10391435
负责人:
Sapna S Gangaputra
金额:
$20.21万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-05-01 至 2024-04-30
关键词:
AdultAgeAnteriorAnterior uveitisBlindnessCataractCataract ExtractionChildChildhoodClinical ResearchCohort StudiesCorneaDataData AnalysesData SetDatabasesDiagnosisDiseaseDisease remissionElectronic Health RecordEtiologyEventEyeEye diseasesFailureFundingGlaucomaGoalsGrantGuidelinesIncidenceInflammationInflammatoryIntermediate UveitisInternational Classification of Disease CodesLightLiteratureMethodsModelingNational Eye InstituteOperative Surgical ProceduresOphthalmologistOutcomePanuveitisPatient-Focused OutcomesPatientsPerceptionPerioperativePersonsPharmaceutical PreparationsPhysiologic Intraocular PressurePostoperative PeriodPredictive FactorPreventionPrognosisRandomized Clinical TrialsRepeat SurgeryResearchResourcesRiskRisk FactorsShunt DeviceSpecialistStrategic PlanningStructural defectStructureSurgical incisionsTherapeutic immunosuppressionTimeTrabeculectomyTubeUnited StatesUnited States National Institutes of HealthUpdateUveitisVisionVisitVisualVisual AcuityVisual impairmentaggressive therapyanalytical methodbasecapsulecohortdisabilityevidence based guidelineseye preservationglaucoma surgeryimprovedpediatric patientspreservationpreventsurgery outcome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project summary
Uveitis is associated with visual impairment and higher incidence of poor outcomes following
intraocular surgery—such as cataract surgery or glaucoma surgery. Guidelines proposed to
prevent visual impairment and achieve successful surgical outcomes include quiescence of
inflammation for atleast 3 months pre-operatively and stringent inflammation control in the
perioperative period, however there is limited evidence on which to based practice regarding the
real-world outcomes for patients who undergo uveitic cataract surgery and uveitic glaucoma
surgery. The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study is a
rich database of uveitis patients (17,907 distinct patients followed over 169,194 visits) with very
detailed information on inflammatory status, medications received, surgeries and other
outcomes. The database includes over 250 children under the age of 18 who have had uveitic
cataract surgery and over 100 children who underwent uveitic glaucoma surgeries, in a field
with very sparse literature on pediatric uveitic cataracts and pediatric uveitic glaucoma. Patients
who had incisional cataract or glaucoma surgery with at least one visit in the 6 months prior to
surgery and at least two post-operative visits beyond 8 weeks postoperatively are included in
the analysis. The results from this grant could (1) guide clinicians and patients re: the optimal
management of patients in the peri-operative period to achieve best possible visual acuity and
intraocular pressure control, (2) explore the incidence of subsequent intraocular surgeries,
especially among children, which would impact the planning of surgeries and (3) guide the peri-
operative management of patients to prevent intraocular inflammation and subsequently the
best visual outcomes. The question of whether to leave a child aphakic or not and whether a
trabeculectomy or tube shunt is associated with longer term intraocular pressure control, thus
preserving visual function, will have evidence-based guidelines through this analysis.
These objectives are responsive to the Strategic Plan and goals of the National Eye Institute, to
support applied clinical research concerning blinding eye diseases and preservation of sight,
especially the goal “Establish the causes and etiology of uveitis and improve methods for its
diagnosis, treatment, and prevention.”
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Incidence of and Risk Factors for Cataract in Anterior Uveitis.
前葡萄膜炎白内障的发病率和危险因素。
DOI:
10.1016/j.ajo.2023.06.021
发表时间:
2023
期刊:
American journal of ophthalmology
影响因子:
4.2
作者:
[Papaliodis,GeorgeN, Rosner,BernardA, Dreger,KurtA, Fitzgerald,TonettaD, Artornsombudh,Pichaporn, Kothari,Srishti, Gangaputra,SapnaS, Levy-Clarke,GraceA, Nussenblatt,RobertB, Rosenbaum,JamesT, Sen,HNida, Suhler,EricB, Thorne,Jennifer]
通讯作者:
Thorne,Jennifer
Molecular characterization of the ocular microbiome in healthy adults
-
批准号:10661148
-
项目类别:
-
资助金额:$63.0万
-
财政年份:2023
-
负责人:Sapna S Gangaputra
-
依托单位:
Outcomes of uveitic cataract and uveitic glaucoma surgery
-
批准号:10193155
-
项目类别:
-
资助金额:$28.61万
-
财政年份:2021
-
负责人:Sapna S Gangaputra
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: